Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS NHI-Market Price Gap on Narrowing Trend, but Results Remain Unpredictable
September 24, 2024
-
REGULATORY More Pregnant Cases Reported for COVID Meds, Panel Urges Greater Caution
September 24, 2024
-
BUSINESS Tsumura to Cover Return Costs for China Staff after Shenzhen Stabbing
September 24, 2024
-
REGULATORY MHLW to Update Decade-Old Generic Roadmap, Add Blueprint for Biosimilars
September 20, 2024
-
BUSINESS Asahi Kasei Pivots toward Drug Business in Healthcare to Drive Growth
September 19, 2024
-
BUSINESS UCB CEO Hails Positive Change in Japan’s Pharma Policy
September 19, 2024
-
BUSINESS GSK’s Multiple Myeloma Drug Blenrep Filed in Japan
September 18, 2024
-
REGULATORY 9 LDP Leader Candidates Showcase Pharma Agendas in Campaign
September 17, 2024
-
BUSINESS Eisai Set on Streamlining Operations to Drive Drug Innovation: COO
September 13, 2024
-
ORGANIZATION Pharma Industry Prepares List of 68 Lawmakers to Support in Likely Snap Poll
September 12, 2024
-
REGULATORY Mounjaro to Keep Price after CEA as Lilly’s Appeal for Raise Nixed
September 12, 2024
-
REGULATORY AMED Research Exploring Low-Cost Method to Analyze Nitrosamine Impurities
September 11, 2024
-
COMMENTARY LLP Info Might Become Inaccessible If New Coverage Rule Speeds Up Exit
September 10, 2024
-
BUSINESS Mitsubishi Chemical Denies Media Report on Pharma Divestiture
September 9, 2024
-
REGULATORY MHLW to Accept English Dossiers from Foreign Makers
September 9, 2024
-
REGULATORY MOF Intent on Expanding Scope of Off-Year Revision in 2025: Budget Examiner
September 6, 2024
-
REGULATORY Japan Poised to Launch FIH Trial System in FY2029 to Attract Global Seeds
September 5, 2024
-
BUSINESS Kidswell Is Open to M&As Amid Challenging Financing Environment: CEO
September 4, 2024
-
BUSINESS BMS Aspires to Double Japan Sales over Next Decade with 5 Growth Drivers
September 3, 2024
-
BUSINESS Takeda Pushes Back Shipping Date as Trucker Overtime Cap Hits Logistics
September 2, 2024
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…